| 1. |
Rahman I, Kinnula V L. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol,2012,5:293-309.
|
| 2. |
Berenson CS, Kruzel RL, Eberhardt E, et al.Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease. J Infect Dis, 2013, 208: 2036-2045.
|
| 3. |
Ween M, Ahern J, Carroll A, et al. A small volume technique to examine and compare alveolar macrophage phagocytosis of apoptotic cells and non typeable Haemophilus influenzae (NTHi). J ImmunolMethods,2016,429:7-14.
|
| 4. |
Mercado N, Kizawa Y, Ueda K, et al. Activation of transcription factor Nrf2 signalling by the sphingosine kinase inhibitor SKI-II is mediated by the formation of Keap1 dimers. PLoS One,2014,9:e88168.
|
| 5. |
Abed D A, Goldstein M, Albanyan H, et al. Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica B,2015,5:285-299.
|
| 6. |
Wang H, Liu K, Geng M, et al. RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res,2013,73:3097-3108.
|
| 7. |
Boutten A, Goven D, Artaud-Macari E, et al. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol Med,2011,17:363-371.
|
| 8. |
Voss M, Wonnenberg B, Honecker A, et al. Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice. Respir Res,2015,16:41.
|
| 9. |
Tschernig T, Rabung A, Voss M, et al. Chronic inhalation of cigarette smoke reduces phagocytosis in peripheral blood leukocytes. BMC Res Notes,2015,8:705.
|
| 10. |
Wu Y, Xu H, Li L, et al. Susceptibility to Aspergillus Infections in Rats with Chronic Obstructive Pulmonary Disease via Deficiency Function of Alveolar Macrophages and Impaired Activation of TLR2. Inflammation,2016,39:1310-1318.
|
| 11. |
Hodge S, Reynolds P N. Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary diseases subjects . Respirology,2012,17:802-807.
|
| 12. |
Ganesan S, Faris A N, Comstock A T, et al. Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A. Am J Pathol,2012,180:61-72.
|
| 13. |
Gerlach K, Kohler-Bachmann S, Jungck D, et al. Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and 慢阻肺 subjects. Eur J Pharmacol,2015,768:123-130.
|
| 14. |
Koarai A, Yanagisawa S, Sugiura H, et al. Cigarette smoke augments the expression and responses of toll-like receptor 3 in human macrophages. Respirology,2012,17:1018-1025.
|
| 15. |
Cosio B G, Jahn A, Iglesias A, et al. Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD. BMC Pulm Med,2015,15:157.
|
| 16. |
Fratta P A, Ferrari M, Stranieri C, et al. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stress. Int J Chron Obstruct Pulmon Dis,2016,11:1733-1743.
|
| 17. |
Harvey C J, Thimmulappa R K, Sethi S, et al. Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model. Science Translational Medicine,2011,3:32r-78r.
|
| 18. |
Mehta A J, Joshi P C, Fan X, et al. Zinc supplementation restores PU.1 and Nrf2 nuclear binding in alveolar macrophages and improves redox balance and bacterial clearance in the lungs of alcohol-fed rats. Alcohol Clin Exp Res,2011,35:1519-1528.
|
| 19. |
Dehn S, Deberge M, Yeap X Y, et al. HIF-2alpha in Resting Macrophages Tempers Mitochondrial Reactive Oxygen Species To Selectively Repress MARCO-Dependent Phagocytosis. J Immunol,2016.
|
| 20. |
Baqir M, Chen C Z, Martin R J, et al. Cigarette smoke decreases MARCO expression in macrophages: implication in Mycoplasma pneumoniae infection. Respir Med,2008,102:1604-1610.
|
| 21. |
Lester Kobzik, Muzo Wu, Glen Deloid, et al. Sulforaphane improves MARCO expression, bacterial clearance and survival in post-influenza bacterial pneumonia.Faseb Journal,2014,28:18-25.
|
| 22. |
Staitieh B S, Fan X, Neveu W, et al. Nrf2 regulates PU.1 expression and activity in the alveolar macrophage. Am J Physiol Lung Cell Mol Physiol,2015,308:L1086-L1093.
|
| 23. |
Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol,2011,85:4679-4690.
|
| 24. |
Joo C R, Cheng M S, Shik K Y. Desoxyrhapontigenin up-regulates Nrf2-mediated heme oxygenase-1 expression in macrophages and inflammatory lung injury. Redox Biol,2014,2:504-512.
|
| 25. |
Ye M, Wang Q, Zhang W, et al. Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation. Biochem Cell Biol,2014,92:337-348.
|
| 26. |
Wang R, Zhang C Y, Bai L P, et al. Flavonoids derived from liquorice suppress murine macrophage activation by up-regulating heme oxygenase-1 independent of Nrf2 activation. Int Immunopharmacol,2015,28: 917-924.
|
| 27. |
Xu X, Li H, Hou X, et al. Punicalagin Induces Nrf2/HO-1Expression via Upregulation of PI3K/AKT Pathway and InhibitsLPS-Induced Oxidative Stress in RAW264.7 Macrophages. Mediators Inflamm,2015,2015:380218.
|
| 28. |
Adenuga D, Caito S, Yao H, et al. Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction. Biochem Biophys Res Commun,2010,403:452-456.
|
| 29. |
Wise R A, Holbrook J T, Criner G, et al. Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. PLoS One,2016,11:e163716.
|
1/5
WeChat